Reduced baseline expression of the tumour suppressor p53 in acne patients compared to acne-free controls may also explain the increased risk of acne patients for common p53-related malignancies such as prostate cancer [109, 110], and breast cancer [111]. The gene discussed is TP53; the disease is prostate carcinoma.